Abstract
Myeloproliferative neoplasms (MPN) are clonal hematological disorders resulting from genetic mutations in the hematopoietic stem cell that promote hyperproliferation and accumulation of precursor and mature myeloid cells in bone marrow and peripheral blood. The BCR-ABL1 negative MPN, in this work, are represented by Polycythemia Vera (PV), Essential Thrombocythemia (ET) and Primary Myelof…